Clinical Trial Update: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the pharmacology and safety of subcutaneously administered C1-esterase inhibitor in hereditary angioedema types I and II has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: CSL Behring | Conditions: Hereditary Angioedema Types I and II | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-01